Validation Suite
Digital Platform
Engineering Services
Smoke Study Visualization
Industry insights and updates
Real-world engineering solutions
Live and on-demand sessions
Downloadable literature
Latest company announcements
A quick read on the updated ISO 14644 audit checkpoints teams are seeing this year.
Turnkey design, cleanroom execution and qualification for advanced therapy manufacturing — engineered right from Day One, not bolted on at the end.
End-to-end compliant infrastructure covering every step of the living-cell journey.
Leukapheresis to collect patient-derived T-lymphocytes under controlled collection protocols.
Controlled material and personnel transfer through Grade C/B airlocks into the cleanroom suite.
Separation and enrichment of target T-cell populations using closed-system processing equipment.
T-cell stimulation with anti-CD3/CD28 beads or reagents in a controlled Grade B environment.
Large-scale cell proliferation in bioreactors to achieve therapeutic dose numbers.
Aseptic filling of the final CAR-T product into patient-specific bags under Grade A conditions.
Controlled-rate freezing and cryogenic storage to preserve cell viability for transport.
Final product released, shipped and infused back into the patient under clinical supervision.
The systems running behind every cleanroom zone — sized, routed and controlled for living-cell manufacturing, long before the walls go up.
HEPA filtration, controlled air changes and pressure cascading tuned to each grade.
Water for injection, clean steam and medical gases delivered to point of use.
Critical power distribution, backup systems and equipment-grade wiring.
Environmental Monitoring Systems for continuous particulate and microbial control.
Process equipment integrated directly into the cleanroom design — not retrofitted after the fact.
Closed-system cell expansion and cultivation equipment integration.
Biosafety cabinets for contained, aseptic cell handling.
Controlled-rate freezing and cryostorage for final product integrity.
Precision-controlled culture environments for cell growth stages.
Photography from live builds and qualified suites — swap in your project's own images here.
Conventional pharma playbooks fall short here. These are the gaps we design against from the first drawing.
Applying traditional pharma facility concepts to CAR-T manufacturing
Complex cleanroom classification requirements across grades
Biosafety & containment challenges unique to living cells
Poor personnel & material flow planning
Utility integration complexity
Delayed compliance planning
Qualification & validation delays
Documentation gaps at handover
Complete project execution under one roof — no vendor handoffs, no compliance left for the end.
CAR-T therapy is transforming the future of cancer treatment, but the most groundbreaking science cannot reach patients without the right GMP infrastructure.
At IncepBio, we recently marked a significant milestone—the commencement of a new Turnkey CAR-T Manufacturing Facility for a client, initiated with a traditional Puja ceremony. Building for cell therapy demands deep integration of process understanding, biosafety, and regulatory strategy from day one.
Let's discuss your project requirements before design begins.
Every CAR-T manufacturing facility is engineered to align with globally recognized pharmaceutical regulations, ensuring compliance, contamination control and operational readiness from design through qualification.
21 CFR, aseptic processing, quality systems and inspection readiness.
Sterile manufacturing principles and contamination control strategy.
Global GMP expectations for regulated pharmaceutical manufacturing.
Cleanroom classification, environmental control and facility performance.
Every project concludes with a complete, structured deliverable package — nothing left to assemble after handover.
Layout, utility and equipment integration drawings.
DQ, IQ, OQ, PQ, FAT and SAT documentation.
Protocols, reports, traceability and risk assessments.
Operational procedures and handover documentation.
Final engineering documentation for future maintenance and compliance.
GMP requirements and validation integrated into project planning from the very first drawing.
Integrated specialists working together throughout project execution.
Specialized understanding of CAR-T and cell therapy facility requirements.
Full project ownership from concept to qualified handover.
Designed to support operational growth and scalability.
Structured packages prepared for inspections and readiness, every time.
CAR-T facilities draw on the same engineering discipline across our other service lines.
IncepBio delivers the engineering, compliance and qualification expertise required for successful project execution.